Euro-K 600
Natural health product licensed in Canada
- Licence holder
- Euro-Pharm International Canada Inc.
- NPN or DIN-HM
- 80084056
- Status
- Active licence
- Licence date
- 27 March 2018
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Potassium: up to 14,976 mg a day according to the dosing instructions published by Health Canada (48 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Potassium Source : Chlorure de potassium | 312 mg | 14,976,000 µg |
Non-medicinal ingredients
Ethylcellulose, Colloidal silicon dioxide, Dioxyde de titane, Triethyl citrate, Huile végétale hydrogénée, simethicone, Bicarbonate de sodium, Laque d'aluminium jaune FD&C No. 6, Lauryl sulfate de sodium, Talc, Triacétine, Hypromellose, Copolymère d'acide méthacrylique et d'acrylate d'éthyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 5 Comprimé ; maximum: 12 Comprimé | minimum: 2 Tous les jours ; maximum: 4 Tous les jours |
| Adultes | Not specified | minimum: 3 Comprimé ; maximum: 5 Comprimé | minimum: 2 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Treatment or prevention of hypokalemia which does not result from dietary deficiency. Treatment of digitalis toxicity. For potassium replacement therapy. As an electrolyte replenish. Treatment of metabolic alkalosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80084056
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.